CLASS II Drug recall · Reported 3 Jan 2024 · FDA Enforcement Report

B-Complex, Thiamine HCI / Riboflavin / Niacinamide recalled

AnazaoHealth is recalling B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI, distributed nationwide in the US. The recall was initiated on 22 Nov 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots: 505075, Exp: 02/05/24; 505596, Exp: 02/06/24; 506155, Exp: 02/07/24; 508103, Exp: 02/13/24; 510837, Exp: 02/19/24; 512411, Exp: 02/20/24; 514856, Exp: 02/25/24; 515642, Exp: 02/28/24; 518309, Exp: 03/05/24; 524262, 524266, Exp: 03/12/24; 524909, Exp: 03/13/24; 526526, Exp: 03/16/24; 529204, Exp: 03/18/24; 530858, Exp: 03/20/24; 535766, Exp: 03/30/24

Quantity recalled5,707 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number: D-0203-2024
FDA event ID: 93500
Recalling firm: AnazaoHealth, Las Vegas, NV
Classification: Class II
Status: Terminated
Recall initiated: 22 Nov 2023
FDA classified: 26 Dec 2023
Reported: 3 Jan 2024
Type: Voluntary: Firm initiated
Customers notified by: Letter
Reason category: Particulate Matter
Drug class: Injectable & IV Drugs

Timeline

22 Nov 2023	Recall initiated by company
26 Dec 2023	Classified by FDA	+34 days
3 Jan 2024	Published in enforcement report	+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter.

Product as listed by the FDA

B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3

Where it was distributed

Nationwide in the USA.

Nationwide

Questions about this recall

Why was it recalled?

Presence of Particulate Matter.

Which lots are affected?

Lots: 505075, Exp: 02/05/24; 505596, Exp: 02/06/24; 506155, Exp: 02/07/24; 508103, Exp: 02/13/24; 510837, Exp: 02/19/24; 512411, Exp: 02/20/24; 514856, Exp: 02/25/24; 515642, Exp: 02/28/24; 518309, Exp: 03/05/24; 524262, 524266, Exp: 03/12/24; 524909, Exp: 03/13/24; 526526, Exp: 03/16/24; 529204, Exp: 03/18/24; 530858, Exp: 03/20/24; 535766, Exp: 03/30/24

Where was it sold?

Nationwide in the USA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 93500

This product is part of a recall event; the main page for the event is Thiamine HCl/Pyridoxine HCl 20 mg/mL /100mg/ml Injection recalled.

Reported	Class	Recall	Company	Reason	Where
3 Jan 2024	CLASS II	Thiamine HCl/Pyridoxine HCl 20 mg/mL /100mg/ml Injection recalled	AnazaoHealth	Particulate Matter	Nationwide

More recalls from AnazaoHealth

All 3

Reported	Class	Recall	Company	Reason	Where
3 Jan 2024Drug	CLASS II	Thiamine HCl/Pyridoxine HCl 20 mg/mL /100mg/ml Injection recalled	AnazaoHealth	Particulate Matter	Nationwide
18 Feb 2015Drug	CLASS II	Compounded Plaquex, intravenous injection vial recalled by AnazaoHealth	AnazaoHealth	Manufacturing (CGMP) Deviations	Nationwide